IGFBP3 and breast carcinoma: IGFBP-3 exerts both growth-stimulatory and apoptotic activity in breast cancer cells, and understanding how its expression is regulated by DNA-damaging agents has implications for predicting how IGFBP-3-expressing tumors may respond to chemotherapy [5].